VHIO has participated in this project coordinated by INCLIVA, which has made it possible to expand knowledge about this type…
colorectal cancer
A study led by researchers at the Hospital del Mar Medical Research Institute shows that the oxaliplatin administered in some…
Presented by VHIO’s Director Josep Tabernero during this week’s annual ASCO Gastrointestinal Cancers Symposium, January 19-21, results from the phase…
The multicenter randomized phase III BREAKWATER trial, spearheaded by VHIO, is the first to evaluate the combination of study drugs…
